Search alternatives:
dynamic properties » thermodynamic properties (Expand search), hydraulic properties (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease dynamic » disease dynamic (Expand search), decreases synaptic (Expand search), decrease glycemic (Expand search)
decrease ligand » decrease and (Expand search), decrease lipid (Expand search), decrease lodging (Expand search)
ligand decrease » and decrease (Expand search), ligand release (Expand search), ligands increased (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
in decrease » in decreased (Expand search), and decrease (Expand search), can decrease (Expand search)
dynamic properties » thermodynamic properties (Expand search), hydraulic properties (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease dynamic » disease dynamic (Expand search), decreases synaptic (Expand search), decrease glycemic (Expand search)
decrease ligand » decrease and (Expand search), decrease lipid (Expand search), decrease lodging (Expand search)
ligand decrease » and decrease (Expand search), ligand release (Expand search), ligands increased (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
in decrease » in decreased (Expand search), and decrease (Expand search), can decrease (Expand search)
1
“... also administered 2 and 24 h after induction. Rats from the non-colitis and non- treated colitis groups...”
Access document
Access document
Article
2
“... of water to investigate the thermodynamic and dynamic properties of stretched and supercooled water...”
Access document
Access document
Article
3
“...-inducing ligand (TRAIL) were detected by ELISA. High mobility group box 1 (HMGB1) was determined by qPCR...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
4
5
6
7
8
9
10
11
12
13
14
15
16
17
“... innovative properties that they can offer to, e.g., the end-use industry or biomedicine. The release of NMs...”
Access document
Access document
18
20